Marking process with radionuclu00ecdeos murine or human antibody, monoclonal or polyclonal anti CD20 antibody associated with immunological disorders and cancer; reagent for diagnosis 'in vivo' and / or 'in vitro,' the basis of murine or human antibody.Monoclonal or polyclonal anti CD20 antibody associated with radionuclu00ecdeos; methods for the in vitro diagnostics and / or in vivo immunological diseases and cancer by using the reagent thus obtained and kit for diagnosis of immunological diseases and cancer is the basis of this reagent.

摘要

Marking process with radionuclu00ecdeos murine or human antibody, monoclonal or polyclonal antibody anti cd2o associated with immunological disorders and cancer; reagent for diagnosis "in vivo" and / or "in vitro," the basis of murine or human antibody.Monoclonal or polyclonal antibody anti cd2o associated with radionuclu00ecdeos; methods for the in vitro diagnostics and / or in vivo immunological diseases and cancer by using the reagent thus obtained and kit for diagnosis of immunological disorders and oncologicas base of this reagent.The present invention relates to a process for marking with radionuclides of murine or human antibody, monoclonal or polyclonal anti cd2o, as well as the reagent for diagnosis in vivo or in vitro the basis of antibodies to cd2o, murine or human monoclonal or polyclonal brand The radionuclide, to their use for diagnosis.The method of in vitro diagnostics "and" in vivo "diseases whose pathophysiology involves the cd2o and kit for diagnosis of diseases using said reagent.